Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

JANXJANX
Showing 8 of 10 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in JANUX THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 1.5M shares of JANX (JANUX THERAPEUTICS INC), worth $23.2M as of 2026-Q2. The position was decreased (-5.7% shares). JANX represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$23.2M

Current Shares

1.5M

Total Value Change

+$22.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-5.7%
$23.2M0.0%$15.36
0
2026-Q1
Decreased
1.6M
-0.8%
$22.2M0.0%$13.44
0
2025-Q4
Increased
1.6M
+129.5%
$22.2M0.0%$13.83
46
2025-Q3
Increased
701,604
+42.5%
$17.1M0.0%$23.70
38
2025-Q2
Increased
492,361
+25.1%
$11.4M0.0%$23.15
34
2025-Q1
Decreased
393,477
-26.5%
$10.6M0.0%$29.10
0
2024-Q4
Increased
535,396
+3592.9%
$28.7M0.0%$52.50
46
2024-Q3
Decreased
14,498
-67.0%
$658,6450.0%$46.25
0

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used